Morgan Stanley
CRVS icon

Morgan Stanley’s Corvus Pharmaceuticals CRVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.58M Buy
894,405
+220,881
+33% +$884K ﹤0.01% 4328
2025
Q1
$2.14M Buy
673,524
+276,160
+69% +$878K ﹤0.01% 4564
2024
Q4
$2.13M Buy
397,364
+4,102
+1% +$21.9K ﹤0.01% 4654
2024
Q3
$2.08M Buy
393,262
+21,859
+6% +$115K ﹤0.01% 4622
2024
Q2
$676K Buy
371,403
+96,042
+35% +$175K ﹤0.01% 5159
2024
Q1
$490K Sell
275,361
-243,949
-47% -$434K ﹤0.01% 5316
2023
Q4
$914K Buy
519,310
+326,804
+170% +$575K ﹤0.01% 5335
2023
Q3
$281K Buy
192,506
+52,871
+38% +$77.2K ﹤0.01% 5432
2023
Q2
$320K Buy
139,635
+39,476
+39% +$90.4K ﹤0.01% 5436
2023
Q1
$91.1K Buy
100,159
+27,554
+38% +$25.1K ﹤0.01% 6045
2022
Q4
$61.7K Buy
72,605
+33,288
+85% +$28.3K ﹤0.01% 6202
2022
Q3
$32K Sell
39,317
-10,031
-20% -$8.16K ﹤0.01% 6594
2022
Q2
$49K Buy
49,348
+8,486
+21% +$8.43K ﹤0.01% 6621
2022
Q1
$67K Buy
40,862
+3,986
+11% +$6.54K ﹤0.01% 6547
2021
Q4
$88K Buy
36,876
+6,933
+23% +$16.5K ﹤0.01% 6511
2021
Q3
$145K Sell
29,943
-7,181
-19% -$34.8K ﹤0.01% 6168
2021
Q2
$99K Sell
37,124
-129
-0.3% -$344 ﹤0.01% 6361
2021
Q1
$115K Sell
37,253
-690
-2% -$2.13K ﹤0.01% 5933
2020
Q4
$135K Buy
37,943
+5,197
+16% +$18.5K ﹤0.01% 5788
2020
Q3
$131K Buy
32,746
+17,704
+118% +$70.8K ﹤0.01% 5300
2020
Q2
$41K Sell
15,042
-17,878
-54% -$48.7K ﹤0.01% 5740
2020
Q1
$69K Sell
32,920
-5,708
-15% -$12K ﹤0.01% 5339
2019
Q4
$210K Sell
38,628
-6,744
-15% -$36.7K ﹤0.01% 5391
2019
Q3
$136K Buy
45,372
+12,741
+39% +$38.2K ﹤0.01% 5327
2019
Q2
$122K Sell
32,631
-24,668
-43% -$92.2K ﹤0.01% 5231
2019
Q1
$230K Buy
57,299
+23,113
+68% +$92.8K ﹤0.01% 4984
2018
Q4
$126K Buy
34,186
+10,394
+44% +$38.3K ﹤0.01% 5461
2018
Q3
$204K Sell
23,792
-7,177
-23% -$61.5K ﹤0.01% 5449
2018
Q2
$340K Buy
30,969
+6,621
+27% +$72.7K ﹤0.01% 5310
2018
Q1
$281K Buy
24,348
+6,275
+35% +$72.4K ﹤0.01% 5318
2017
Q4
$187K Buy
18,073
+3,937
+28% +$40.7K ﹤0.01% 5435
2017
Q3
$226K Buy
14,136
+5,216
+58% +$83.4K ﹤0.01% 5295
2017
Q2
$109K Buy
8,920
+4,205
+89% +$51.4K ﹤0.01% 5601
2017
Q1
$98K Sell
4,715
-5,256
-53% -$109K ﹤0.01% 5606
2016
Q4
$142K Buy
9,971
+9,063
+998% +$129K ﹤0.01% 5462
2016
Q3
$15K Buy
+908
New +$15K ﹤0.01% 6002
2016
Q2
Sell
-219
Closed -$3K 6533
2016
Q1
$3K Buy
+219
New +$3K ﹤0.01% 6355